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ABSTRACT
We determined the presence of four virulence genes: (cna, seh, PVL, TSST-1) using multiplex PCR in 880 isolates of
methicillin-susceptible Staphylococcus aureus (MSSA) collected from the Universiti Kebangsaan Malaysia Medical
Centre (UKMMC) in 2009. We found that 51.59% (454/880) of the strains had cna; 21.82% (192/880) possessed seh;
10.23% (90/880) had PVL and 6.82% (60/880) haboured TSST-1. Although methicillin-susceptible, MSSA carries
important virulence genes which could affect patient’s clinical course.
INTRODUCTION
Staphylococcus aureus is a major nosocomial pathogen
that causes a wide range of diseases including endocarditis,
osteomyelitis, pneumonia, toxic-shock syndrome, food
poisoning, carbuncle and boils [1]. Its pathological
importance makes it a longstanding subject of
epidemiological investigation. In recent years, such studies
have typically involved genotyping via a variety of
molecular techniques. In one such effort, researchers have
used the presence or absence of virulence elements to
characterize isolates [2], where a multiplex-PCR protocol was
developed for virulence gene detection of S. aureus [3].
Epidemiological studies are usually carried out for
methicillin-resistant S. aureus (MRSA) due to its importance
in drug resistance. In comparison, less emphasis has been
placed on methicillin-susceptible S. aureus (MSSA) isolates,
even though they are often more genetically variable and
have a higher hospital prevalence (20-40%) than MRSA (5-
10%) [4,5,6]. In this pilot study on MSSA isolates in our
university hospital, we collected the index (first isolate from
each patient) MSSA isolates of all MSSA infections reported
in the hospital in 2009 and detected the presence of four
clinically important virulence genes in these isolates.
MATERIALS AND METHODS
BACTERIAL STRAINS
The Universiti Kebangsaan Malaysia Medical Centre
(UKMMC) is a teaching hospital with a capacity of 900
beds located in the centre of Kuala Lumpur. From January
to December 2009, a total of 880 cases of MSSA related
infections from various wards of the hospital were reported.
We collected the index MSSA isolate of each case and
established these as strains. Most strains were isolated
from tissue and wound swabs. Species identification of
staphylococci was performed by the Department of Medical
Microbiology and Immunology, UKMMC. Strains were
stocked from time of isolation in Brain Heart Infusion broth
with 40% glycerol at -70oC.
GENOMIC DNA ISOLATION
Chromosomal DNA of each MSSA strain was extracted
using DNeasy Blood & Tissue Kit (Qiagen) according to
the manufacturer’s instruction. The quantity and quality
of DNA were determined spectrophotometrically. Extracted
DNA samples were stored at -20 oC.
VIRULENCE GENE TYPING
The presence of four virulence genes, cna, seh, PVL and
TSST-1 in our collection of MSSA strains were determined
by a modified multiplex-PCR (M-PCR) protocol [7]. M-PCR
was performed in 25 µl reaction volumes containing the
following: 2x PCR buffer (PROMEGA), 3 mM MgCl2, 400
µM of each dNTP, 2.5 U Taq DNA Polymerase, 1 µl DNA
template and 10 mM of each primer. Primer sequences for
the genes are shown in Table 1. The cycle program for M-
PCR was as follows: 1 cycle of pre-denaturation for 4 min at
94°C; 30 cycles of 94°C for 2 min (denaturation), 58°C for 1
min (annealing) and 72°C for 2 min (extension); and a final
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extension at 72°C for 5 min. M-PCR products were analysed
by gel electrophoresis with a 1.5% agarose gel (Sigma). S.
aureus strains 81/108 (PVL), WIS (TSST) and clinical isolate
MSSA 251 (cna, seh) were used as positive controls for M-
PCR. 81/108 and WIS were kindly provided by Keiichi
Hiramatsu and Teruyo Ito (Juntendo University, Japan).
RESULTS AND DISCUSSION
More attention has been focused towards MRSA as they
are usually multidrug resistant and pose a challenge for
antibiotic prescription [8]. Nevertheless, MSSA has a higher
prevalence than MRSA in most hospitals, and they were
reported to bring certain degree of morbidity and mortality
if not properly monitored [9]. Even though they are usually
susceptible to many antibiotics, MSSA has been reported
to harbor various virulence genes, such as PVL, which
could cause potentially fatal necrotizing pneumonia [2].
Our university hospital is a tertiary hospital which not
only accepts admission from patients residing in Kuala
Lumpur, but also referrals from various hospitals in the
rural areas. In 2009, the percentage of MSSA infections
among S. aureus cases in UKMMC was as high as 73.4%
(880 cases out of 1199 S. aureus infections). This is almost
similar to another tertiary hospital in Spain (70.4%) [10]. In
contrast, MSSA prevalence in Australian and Nepalese
tertiary hospitals were lower at 62.7 and 55.1%, respectively
[8, 9].
In this study, we determined the prevalence of four
virulence genes, cna, seh, PVL and TSST-1 in index MSSA
isolates collected from various wards of UKMMC in 2009.
cna is a staphylococcal virulence factor involved in
attachment of S. aureus to cells or extracellular matrices,
where it codes for a collagen adhesin [11]. Collagen adhesin
is an important step for the pathogenesis of staphylococcal
arthritis and osteomyelitis; it mediates the attachment of S.
aureus cells to cartilage [12]. We found 51.59% of the MSSA
strains in our study haboured the cna gene, which was
also the most prevalent virulence factor among the four
genes that we investigated (Figure 1). About 12% (105/
880) of the MSSA cases in UKMMC in 2009 were from the
orthopedic ward (unpublished observation), where cna was
detected in 55.24% (58/105) of these strains.
seh encodes for staphylococcal enterotoxin H (SEH),
which is one of the newly reported staphylococcal
Table 1. Primers used for detection of virulence genes
Primer Sequence Product size (bp) Reference
cna-1 5’-ACACCAGACGGTGCAACAATTA-3’
cna-2 5’-AGCAATACCGTTTGCATCTGTTA-3’ 815 7
seh-F 5’-ATTCACATCATATGCGAAAGCAG 3’
seh-R 5’-ATGTCGAATGAGTAATCTCTAG-3’ 555 7
pvl-F 5’-ATGTCTGGACATGATCCAA-3’
pvl-R 5’-AACTATCTCTGCCATATGGT-3’ 970 7
TSST-1 5’-TGATATGTGGATCCGTCAT-3’
TSST-1 5’-AAACACAGATGGCAGCAT-3’ 387 7
Figure 1. The prevalence of 4 virulence genes (cna, seh, PVL and TSST-1) in index MSSA strains isolated from UKMMC, 2009
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enterotoxin [13]. Reports show that most seh-harboring S.
aureus isolates were able to produce a significant amount
of SEH, leading to food poisoning and staphylococcal
superantigen-related diseases. In UKMMC, the prevalence
of the seh gene was 21.82%, which is higher than those
reported by Becker et al. (5%) [14] and Peacock et al. (15%)
[15]. These differences in prevalence might be due to the
role of seh in invasive illnesses [16]: 50% of the strains
used in the studies of Becker et al. and Peacock et al. were
isolated from the anterior nares of healthy individuals,
therefore the prevalence of seh in their strains were lower
compared to our study, where all of our MSSA were isolated
from ill, hospitalized patients.
Interestingly, the prophage sequence encoding
Panton-Valentine leukocidin (PVL), a cytotoxin usually
associated with community-acquired MRSA, was detected
in 10.23% of MSSA strains and this prevalence was higher
than another report by Sila et al. (3%) [2]. PVL lyses
leukocytes and several findings linked PVL positive strains
to necrotizing pneumonia and severe skin infections [17].
Nevertheless, it is still controversial if the cytotoxin itself
is pathogenic [17].
Toxic shock syndrome (TSS) is an acute systemic
disease characterised by fever, hypotension, myalgia, rash,
multiple-organ failure, and late desquamation of the hands
and feet [18]. It is caused by the Toxic Shock Syndrome
Toxin (TSST), a superantigen produced by S. aureus
isolates carrying the tst gene, where TSST-1 is the common
form of exotoxin related to TSS. In our study, the TSST-1
gene was present in 6.82% isolates, which is comparable to
that of Sila et al’s [2] investigation. Nevertheless, it is lower
than those published by Becker et al. [14] who reported an
18% and 22% prevalence of TSST-1 in strains isolated from
blood and nasal specimens, respectively.
CONCLUSION
Most S. aureus isolates from UKMMC in 2009 were still
susceptible to methicillin (73.4%). Nevertheless, this current
study on the prevalence of four important virulence genes
in these isolates revealed that about half (58.75%) of these
MSSA isolates haboured virulence factors, where the most
commonly detected virulence gene was cna (51.59%). Even
though MSSA infections are generally easier to manage as
they are commonly susceptible to most available antibiotics,
infections with MSSA should be treated be caution as they
could still serve as reservoirs of virulence factors and
introduce complications into patients’ clinical course.
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